NL6613830A - - Google Patents

Info

Publication number
NL6613830A
NL6613830A NL6613830A NL6613830A NL6613830A NL 6613830 A NL6613830 A NL 6613830A NL 6613830 A NL6613830 A NL 6613830A NL 6613830 A NL6613830 A NL 6613830A NL 6613830 A NL6613830 A NL 6613830A
Authority
NL
Netherlands
Application number
NL6613830A
Other versions
NL154733B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6613830A publication Critical patent/NL6613830A/xx
Publication of NL154733B publication Critical patent/NL154733B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
NL666613830A 1965-10-01 1966-09-30 Werkwijze voor het bereiden van een 2-(2-chlooranilino)-diazacyclopenteen-2 met bloeddrukverlagende sedatieve werking. NL154733B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0083965 1965-10-01

Publications (2)

Publication Number Publication Date
NL6613830A true NL6613830A (cs) 1967-04-03
NL154733B NL154733B (nl) 1977-10-17

Family

ID=6982209

Family Applications (1)

Application Number Title Priority Date Filing Date
NL666613830A NL154733B (nl) 1965-10-01 1966-09-30 Werkwijze voor het bereiden van een 2-(2-chlooranilino)-diazacyclopenteen-2 met bloeddrukverlagende sedatieve werking.

Country Status (15)

Country Link
US (1) US3462433A (cs)
BE (1) BE687657A (cs)
BR (1) BR6683312D0 (cs)
CH (1) CH484913A (cs)
CS (2) CS155151B2 (cs)
DE (1) DE1545628A1 (cs)
DK (1) DK115773B (cs)
ES (1) ES331788A1 (cs)
FI (1) FI46380C (cs)
FR (2) FR5772M (cs)
GB (1) GB1144230A (cs)
IL (1) IL26612A (cs)
NL (1) NL154733B (cs)
PL (1) PL79192B1 (cs)
SE (1) SE331281B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2316377C3 (de) * 1973-04-02 1978-11-02 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Verfahren zur Herstellung von 2-Phenyl-amino-2-imidazolin-Derivaten und von deren Salzen
DE2658808A1 (de) * 1976-12-24 1978-07-06 Boehringer Sohn Ingelheim 2-brom-3-chlor-n-2-imidazolidinylen- benzamin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
US4262005A (en) * 1978-05-31 1981-04-14 The Boots Company Limited Compounds, compositions and methods for controlling pests
DE2854659A1 (de) * 1978-12-18 1980-07-10 Boehringer Sohn Ingelheim Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE2855306A1 (de) * 1978-12-21 1980-07-10 Boehringer Sohn Ingelheim Mittel zur senkung der herzfrequenz
CA1175434A (en) 1980-09-10 1984-10-02 Hoffmann-La Roche Limited ¬(2-phenylamino-1-imidazolidinyloxy)methyl| pyridine 1-oxide derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899426A (en) * 1959-08-11 Synthesis of l
CA625631A (en) * 1961-08-15 Chas. Pfizer And Co. Derivatives of diazacycloalkenes
US3190802A (en) * 1961-10-09 1965-06-22 Boehringer Sohn Ingelheim Shaving composition and method of using same
NL123037C (cs) * 1963-10-04

Also Published As

Publication number Publication date
NL154733B (nl) 1977-10-17
CH484913A (de) 1970-01-31
US3462433A (en) 1969-08-19
IL26612A (en) 1970-08-19
FR5772M (cs) 1968-03-11
BE687657A (cs) 1967-03-30
FI46380B (cs) 1972-11-30
CS155151B2 (cs) 1974-05-30
CS155152B2 (cs) 1974-05-30
FR1506408A (fr) 1967-12-22
FI46380C (fi) 1973-03-12
DE1545628A1 (de) 1970-06-25
BR6683312D0 (pt) 1973-12-26
GB1144230A (en) 1969-03-05
PL79192B1 (en) 1975-06-30
ES331788A1 (es) 1967-11-01
DK115773B (da) 1969-11-10
SE331281B (cs) 1970-12-21

Similar Documents

Publication Publication Date Title
JPS5017470B1 (cs)
JPS459751Y1 (cs)
JPS432591Y1 (cs)
JPS5329845B1 (cs)
JPS5439460B1 (cs)
JPS4418718Y1 (cs)
JPS461250Y1 (cs)
JPS482277Y1 (cs)
BE674663A (cs)
BE674476A (cs)
NL6600135A (cs)
NL6610958A (cs)
NL6615916A (cs)
SE332205B (cs)
BE681859A (cs)
BE675028A (cs)
BE674969A (cs)
BE674940A (cs)
BE674901A (cs)
BE674890A (cs)
BE674825A (cs)
BE674776A (cs)
BE674710A (cs)
BE674664A (cs)
NL6613830A (cs)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: BOEHRINGER

V4 Discontinued because of reaching the maximum lifetime of a patent